There has never been a more exciting time to join us - you will take the lead, managing direct marketing campaigns for our gaming portfolio with a fundraising objective whilst actively contributing to an integrated approach to scaling beneficiary and supporter engagement.
In this section you can find the answers to the questions most frequently asked by our supporters. If you have any further questions about donating that aren't answered here, please call 0300 330 0740 or email firstname.lastname@example.org
The National Institute of Clinical Excellence (NICE) are currently welcoming applications from people who would like to join the groups that develop Quality Standards.
A panel of independent experts has decided that alteplase, a clot-busting drug often used to treat strokes is safe and effective under current guidelines.
Published in the journal Age and Ageing, a new systematic review of the current research suggests that anticoagulant drugs may have cognitive benefit for those with AF (atrial fibrillation).
We’re looking for a skilled influencer with strong experience of managing campaigns, projects and relationships across organisational boundaries. This is a fantastic role for someone looking to develop their career and deliver amazing impact for stroke survivors and their families by shaping the direction of an ambitious and well-respected charity.
No two strokes are alike - the damage from each stroke leaves its own unique signature on a person's brain and behaviour. The current project will investigate how different types of stroke affect a person's long term recovery or deterioration
Raconteur is a publishing house and agency which produces special reports and commentary for the Times and Sunday Times.
Published on Saturday 9 May 2015, the 'Understanding Stroke 2015' report consists of a number articles covering different areas of current stroke news.
The European Stroke Organisation Conference (ESOC) 2018 is currently on from 16-18 May in Gothenburg, Sweden. The first day of ESOC included some truly inspiring scientific sessions, including the WAKE-UP trial, RIGHT-2 trial and CROMIS-2 trials.